Ligand validation:5LVV

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5LVV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LVV_NAG_A_1202	55%	35%	0.198	0.969	0.88	1.68	-	1	0	0	100%	0.9333
5LVV_NAG_A_1204	53%	29%	0.183	0.956	0.89	1.92	-	4	6	0	93%	0.9333
5LVV_NAG_A_1203	18%	9%	0.293	0.893	1.53	2.93	3	11	2	0	93%	0.9333
4GYW_NAG_D_101	93%	67%	0.062	0.957	0.43	0.82	-	-	0	0	100%	0.9333
5HGV_NAG_D_101	66%	59%	0.153	0.959	0.96	0.62	1	1	0	0	100%	0.9333
4AY5_NAG_I_1202	64%	10%	0.173	0.972	1.77	2.56	4	5	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.